Clinical Trial

LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to collect sensor data from insertable cardiac monitor systems.
Protocol Amendment History 3 changes
notable Primary completion pushed: 2026-07 -> 2026-07-31 2026-08-05
notable Primary completion pushed: 2026-05 -> 2026-07 2026-06-03
minor Completion pushed: 2026-06 -> 2026-11 2026-06-03
Trial Details
NCT Number NCT04790344
Lead Sponsor Boston Scientific Corporation
Conditions Heart Failure
Enrollment 525 participants
Start Date 2021-03-20
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-08-04